hydroxyindoleacetic acid and 3-iodobenzylguanidine

hydroxyindoleacetic acid has been researched along with 3-iodobenzylguanidine in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (28.57)18.2507
2000's4 (57.14)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Derksen, J; Hogendoorn, PC; Mandigers, CM; van der Mey, AG; van Gils, AP1
Boot, H; Hoefnagel, C; Taal, BG; Valdes Olmos, R; Zuetenhorst, H1
Ahlman, H; Ahrén, B; Bernhardt, P; Forssell-Aronsson, E; Johanson, V; Karlsson, S; Kölby, L; Nilsson, O; Stenman, G; Wängberg, B; Wigander, A1
Hoefnagel, CA; Muller, M; Taal, BG; Valdes Olmos, RA; Zuetenhorst, JM1
Coleman, RE; Feldman, J; Gockerman, JP; Moore, J; Olson, JA; Onaitis, MW; Safford, SD; Tyler, DS1
Chan, AK; Eick, G; Kidd, M; Latich, I; Modlin, IM; Zikusoka, M1
Bodoky, G; Pregun, I; Rácz, K; Tulassay, Z1

Reviews

2 review(s) available for hydroxyindoleacetic acid and 3-iodobenzylguanidine

ArticleYear
Gastrointestinal carcinoids: the evolution of diagnostic strategies.
    Journal of clinical gastroenterology, 2006, Volume: 40, Issue:7

    Topics: 3-Iodobenzylguanidine; Biomarkers, Tumor; Bone and Bones; Bone Neoplasms; Capsule Endoscopy; Carcinoid Tumor; Chromogranin A; Endosonography; Gastrointestinal Neoplasms; Humans; Hydroxyindoleacetic Acid; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Somatostatin

2006
[Carcinoid tumors].
    Orvosi hetilap, 2010, Nov-14, Volume: 151, Issue:46

    Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Biomarkers, Tumor; Bronchial Neoplasms; Carcinoid Tumor; Chromogranin A; Clinical Trials as Topic; Dacarbazine; Early Detection of Cancer; Gastrointestinal Neoplasms; Heterocyclic Compounds; Humans; Hydroxyindoleacetic Acid; Lung Neoplasms; Organometallic Compounds; Prevalence; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Somatostatin; Temozolomide; Thalidomide; TOR Serine-Threonine Kinases; Treatment Outcome

2010

Trials

1 trial(s) available for hydroxyindoleacetic acid and 3-iodobenzylguanidine

ArticleYear
Interferon and meta-iodobenzylguanidin combinations in the treatment of metastatic carcinoid tumours.
    Endocrine-related cancer, 2004, Volume: 11, Issue:3

    Topics: 3-Iodobenzylguanidine; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoid Tumor; Disease Progression; Female; Humans; Hydroxyindoleacetic Acid; Interferon alpha-2; Interferon-alpha; Intestinal Neoplasms; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Recombinant Proteins; Stomach Neoplasms; Survival Rate; Tomography, Emission-Computed

2004

Other Studies

4 other study(ies) available for hydroxyindoleacetic acid and 3-iodobenzylguanidine

ArticleYear
Carcinoid tumor of the jugulo-tympanic region.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1996, Volume: 37, Issue:2

    Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Carcinoid Tumor; Contrast Media; Ear Neoplasms; Ear, Middle; Humans; Hydroxyindoleacetic Acid; Iodine Radioisotopes; Iodobenzenes; Magnetic Resonance Imaging; Male; Middle Aged; Paraganglioma, Extra-Adrenal; Radionuclide Imaging; Serotonin

1996
Long-term palliation in metastatic carcinoid tumours with various applications of meta-iodobenzylguanidin (MIBG): pharmacological MIBG, 131I-labelled MIBG and the combination.
    European journal of gastroenterology & hepatology, 1999, Volume: 11, Issue:10

    Topics: 3-Iodobenzylguanidine; Adult; Aged; Antineoplastic Agents; Carcinoid Tumor; Combined Modality Therapy; Fatal Outcome; Female; Humans; Hydroxyindoleacetic Acid; Iodine Radioisotopes; Liver Neoplasms; Middle Aged; Palliative Care; Radionuclide Imaging; Radiopharmaceuticals; Remission Induction; Tomography, X-Ray Computed

1999
A transplantable human carcinoid as model for somatostatin receptor-mediated and amine transporter-mediated radionuclide uptake.
    The American journal of pathology, 2001, Volume: 158, Issue:2

    Topics: 3-Iodobenzylguanidine; 5-Hydroxytryptophan; Animals; Biogenic Amines; Calcium; Carcinoid Tumor; Carrier Proteins; Chromogranin A; Chromogranins; Chromosome Painting; Disease Models, Animal; Female; Gene Expression Regulation, Neoplastic; Humans; Hydroxyindoleacetic Acid; Ileal Neoplasms; Immunohistochemistry; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Nude; Middle Aged; Neuropeptides; Octreotide; Radioisotopes; Receptors, Somatostatin; RNA, Messenger; Serotonin; Substance P; Transplantation, Heterologous; Tumor Cells, Cultured; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins

2001
Iodine-131 metaiodobenzylguanidine treatment for metastatic carcinoid. Results in 98 patients.
    Cancer, 2004, Nov-01, Volume: 101, Issue:9

    Topics: 3-Iodobenzylguanidine; Adult; Aged; Carcinoid Tumor; Female; Humans; Hydroxyindoleacetic Acid; Intestinal Neoplasms; Iodine Radioisotopes; Male; Middle Aged; Retrospective Studies

2004